Synthesis and SAR of 1,9-dihydro-9-hydroxypyrazolo[3,4-b]quinolin-4-ones as novel, selective c-Jun N-terminal kinase inhibitors.

Bioorg Med Chem Lett

Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064-6098, USA.

Published: May 2006

A novel class of 1,9-dihydro-9-hydroxypyrazolo[3,4-b]quinolin-4-ones as c-Jun-N-terminal kinase (JNK) inhibitors is described. These compounds were synthesized via the condensation of 2-nitrobenzaldehydes and hydroxypyrazoles. The structure-activity relationships (SAR) and kinase selectivity profile of the inhibitors are also discussed. Compound 16 was identified as a potent JNK inhibitor with good cellular potency.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2006.02.046DOI Listing

Publication Analysis

Top Keywords

synthesis sar
4
sar 19-dihydro-9-hydroxypyrazolo[34-b]quinolin-4-ones
4
19-dihydro-9-hydroxypyrazolo[34-b]quinolin-4-ones novel
4
novel selective
4
selective c-jun
4
c-jun n-terminal
4
n-terminal kinase
4
kinase inhibitors
4
inhibitors novel
4
novel class
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!